I wanted to add some commentary on Glycomimetics (GLYC) as I own shares – all of them under 1 dollar as I said I would buy once prior management was removed. The prior management well, mismanaged the company’s trials -…
Tag: pharma
Updated: Immunotherapy-Oncology Webinar – Monday May 23rd @ 1 PM EST.
What is immunotherapy? Danny Cohen and myself will be doing a live webinar on Monday May 23rd at 1 pm EST, 10 am Western time. The webinar will be recorded and uploaded to this site afterwards. Topics explained and included…
Bullish Free Articles Bullish Free Videos Commentary Free Articles Commentary Free Videos Free Articles Free Videos
Why This Small Cap Biotech Is Likely To Rally Soon
In small cap developmental biotech, we see a lot of creative financing, and when we understand how it works, we can profit from it. These types of biotech charts normally trade in a consistent ‘channel pattern.’ and when we spot…
Sunshine Heart’s Pulse System Could Revolutionize How Heart Failure Is Treated
Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted…
Important Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Video: Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013. $ONTX $INSM $AEGR $AUXL plus commentary on Market conditions and current chatter concerning the latest “terrorist threats,” and more!
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals
Recently, we have detailed companies that have released positive Phase III data because we believe several of these companies continue to be under speculation value. Companies who have strong management, cash, and a strong pipeline can be very profitable for…
Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included.
